Table 1. Diseases and their opportunity guarantees considered in the study.
GES–OG | Disease | Description OG | OG [days] |
---|---|---|---|
GES17-a | Lymphomas (≥ 15y) | Diagnostic confirmation to staging | 30 |
GES17-b | Lymphomas (≥ 15y) | Staging to chemotherapy (1) | 10 |
GES25 | Impulse generation and driving disorders requiring a pacemaker (≥ 15y) | Diagnostic confirmation to treatment | 30 |
GES26 | Preventive cholecystectomy (≥ 35y and ≤ 49y) | Diagnostic confirmation to surgery | 90 |
GES27 | Gastric cancer | Diagnostic confirmation to treatment | 30 |
GES31 | Diabetic retinopathy | Diagnostic confirmation to treatment | 60 |
GES32 | Nontraumatic rheumatogenous retinal detachment | Diagnostic confirmation to treatment | 7 |
GES37 | Ischemic stroke (≥ 15y) | Diagnostic confirmation to treatment | 1 |
GES42 | Subarachnoid hemorrhage secondary to ruptured brain aneurysms | Diagnostic confirmation to treatment | 1 |
GES43 | Primary tumors of the central nervous system | Diagnostic confirmation to treatment | 30 |
GES49 | Moderate or severe head trauma | Diagnostic confirmation to treatment | 1 |
GES50 | Severe eye trauma | Diagnostic confirmation to treatment | 3 |
GES67 | Recurrent remitting multiple sclerosis | Diagnostic confirmation to treatment | 30 |
GES69 | Hepatitis C | Diagnostic confirmation to pre-treatment | 30 |
GES70 | Colorectal cancer (≥ 15y) | Diagnostic confirmation to staging | 45 |
GES73 | Osteosarcoma (≥ 15y) | Medical indication to treatment (2) | 30 |
OG: opportunity guarantee.
GES–OG: specific opportunity guarantee for a given disease.
(1) Staging is the process through examinations and tests to learn the extent of the cancer within the body.
(2) We assume medical indication is equivalent to diagnostic confirmation.